A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis.
Eyebiotech Limited: EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.